戻る
Verastem Inc (VSTM)価格
VSTM 株価推移チャート
VSTM 収入
Verastem Inc
$5.71
-2.55%
$-0.15
終値： Feb 18, 16:00:00 GMT-5
$5.71
0.13%
$0
アフターマーケット：Feb 18, 20:00:00 GMT-5
主要データ
前終値
$5.86
始値
$5.84
当日レンジ
$5.69 - $5.96
52週レンジ
$4.01 - $11.25
取引高
1.4M
平均取引高
1.9M
1株当たり利益(TTM)
-3.61
配当利回り
--
時価総額
$441.1M
VSTMとは何ですか？
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company is headquartered in Needham, Massachusetts and currently employs 78 full-time employees. The company went IPO on 2011-11-08. Its product candidates include avutometinib and defactinib. Avutometinib is an oral RAF/MEK clamp that inhibits MEK1/2 kinase activities and induces inactive complexes of MEK with A-Raf proto-oncogene, potentially serine/threonine kinase (ARAF), B-Raf proto-oncogene serine/threonine kinase (BRAF) and C-raf proto-oncogene serine/threonine kinase, creating antitumor response through maximal RAS/MAPK pathway inhibition. Defactinib is an oral, selective inhibitor of FAK and proline-rich tyrosine kinase (PYK2), the two members of the focal adhesion kinase family of non-receptor protein tyrosine kinases. FAK and PYK2 integrate signals from integrin and growth factor receptors to regulate cell proliferation.